FEATURED/ARCHIVES (05/05/24)
Quetiapine for the Management of Tardive Dyskinesia in Schizoaffective Disorder Comorbid with Diabetes Mellitus and Chronic Kidney Disease · February 2021
Articles
Primary Care Companion for CNS Disorders
A Systematic Review of Clinical Trials on Lumateperone and Its Effects on Body Weight · September 2022
Abstracts
Journal of Clinical Psychopharmacology
Characteristics of Voluntary Reporting of Adverse Drug Events Related to Antipsychotics in Australia: 14-Year Analysis · May 2021
Articles
Therapeutic Advances in Drug Safety
Antipsychotic Drug Development: From Historical Evidence to Fresh Perspectives · June 2022
Articles
Frontiers in Psychiatry
Long-Term Methylphenidate Use for Children and Adolescents with Attention Deficit Hyperactivity Disorder and Risk for Depression, Conduct Disorder, and Psychotic Disorder: A Nationwide Longitudinal Cohort Study in South Korea · October 2022
Articles
Child and Adolescent Psychiatry and Mental Health
Single Trajectory Treatment Response for Predominant Negative Symptoms: Post-Hoc Analysis of a Clinical Trial with Cariprazine and Risperidone · September 2023
Articles
Schizophrenia Research
A Pregnant Patient with Schizophrenia – Dilemmas of Treatment and Care: A Problem Still Not Only for Psychiatrists · August 2020
Articles
Psychiatria Polska
Blinded SAPS-PD Assessment After 10 Weeks of Pimavanserin Treatment for Parkinson’s Disease Psychosis · October 2020
Articles
Journal of Parkinson’s Disease
Risks of All-Cause Death and Completed Suicide in Patients with Schizophrenia/Schizoaffective Disorder Treated with Long-Acting Injectable or Oral Antipsychotics: A Population-Based Retrospective Cohort Study in Taiwan · December 2021
Articles
European Psychiatry
Antipsychotic Drug Treatment of Schizophrenia in Later Life: Results from the European Cross-Sectional AMSP Study · December 2021
Articles
World Journal of Biological Psychiatry
Second Generation Long-Acting Injectable Antipsychotics in Schizophrenia: The Patient’s Subjective Quality of Life, Well-Being, and Satisfaction · November 2023
Articles
Journal of Clinical Medicine
Attitudes and Willingness to Accept Long-Acting Injections for Patients with Schizophrenia in Beijing: A Cross-Sectional Investigation Based on Samples from the Communities · November 2021
Articles
Frontiers in Public Health
Antipsychotic Polypharmacy among Patients with Schizophrenia in Africa: A Systematic Review and Meta-Analysis · July 2021
Articles
International Journal of Neuropsychopharmacology
Lurasidone in Adolescents and Adults with Schizophrenia: From Clinical Trials to Real-World Clinical Practice · November 2022
Articles
Expert Opinion on Pharmacotherapy
Network Pharmacology and Molecular Docking Analysis on Targets and Mechanisms of Berberine in Atypical Antipsychotic-Induced Metabolic Syndrome · October 2022
Articles
Natural Product Communications
Using Open Questions to Understand 650 People’s Experiences with Antipsychotic Drugs · February 2020
Articles
Schizophrenia Bulletin
Guidelines for Discontinuation of Antipsychotics in Patients Who Recover from First-Episode Schizophrenia Spectrum Disorders: Derived from the Aggregated Opinions of Asian Network of Early Psychosis Experts and Literature Review · April 2022
Articles
International Journal of Neuropsychopharmacology
Psychiatric and Non-Psychiatric Polypharmacy among Older Adults with Schizophrenia: Trends from a Population-Based Study between 2000 and 2016 · February 2023
Articles
Frontiers in Pharmacology
Adverse Events of Antipsychotics and Cytochrome Polymorphisms: A Case Series on 31 Patients · December 2021
Articles
NCBI>Psychiatria Danubina